Observational Study of Cognitive and Neurological Health in Pompe Disease

This observational study aims to understand the long-term effects of Pompe disease on the brain and nerves in children and teenagers. Researchers want to see if there are any unusual changes in the brain and nerves, and how these changes relate to a child's development. You could be eligible if you are between 0 and 18 years old and have a confirmed diagnosis of infantile Pompe disease (IPD) or late-onset Pompe disease (LOPD). The study will use brain scans (like MRI) to look for these changes. The goal is to learn more about how Pompe disease affects the central nervous system (CNS) in patients receiving enzyme replacement therapy (ERT). This study is currently unclear on its recruitment status.

Study design
This is an observational study planning to enroll 45 participants. It is not testing a specific intervention or drug.
What's involved
You would participate in clinic visits and assessments, including brain imaging (MRI, MRS, DTI), tests for thinking skills, academic skills, speech, language, physical therapy, and muscle ultrasound. Your participation would last for at least 3 years and up to 6 years.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, involving neuroimaging, will be measured for up to 6 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04639336

Cognitive and Neurological Pathologies in Pompe Disease

Recruiting
Not specifiedAges 0–18Observational
Duke University
~45 participants
Updated 2026-03-04 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To determine the involvement of central nervous system (CNS) pathology in long-term survivors of IPD and early diagnosed LOPD patients being treated with enzyme replacement therapy (ERT) as measure by neuroimaging.
Measured over up to 6 years
Pompe Disease

NCT04639336

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Duke University Medical Center

    Durham, North Carolinastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Priya Kishnani, MD · PRINCIPAL_INVESTIGATOR · Duke University

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Subject has a confirmed and documented diagnosis of infantile Pompe Disease (IPD) or Late onset Pompe Disease (LOPD)

Exclusion

Refusal to give informed consent
  • To determine the involvement of central nervous system (CNS) pathology in long-term survivors of IPD and early diagnosed LOPD patients being treated with enzyme replacement therapy (ERT) as measure by neuroimaging.up to 6 years